SE0302422D0 - Peptide-based immunization therapy for treatment of atherosclerosis - Google Patents

Peptide-based immunization therapy for treatment of atherosclerosis

Info

Publication number
SE0302422D0
SE0302422D0 SE0302422A SE0302422A SE0302422D0 SE 0302422 D0 SE0302422 D0 SE 0302422D0 SE 0302422 A SE0302422 A SE 0302422A SE 0302422 A SE0302422 A SE 0302422A SE 0302422 D0 SE0302422 D0 SE 0302422D0
Authority
SE
Sweden
Prior art keywords
peptide
atherosclerosis
treatment
cardiovascular diseases
immunization therapy
Prior art date
Application number
SE0302422A
Other languages
English (en)
Swedish (sv)
Inventor
Goeran Hansson
Original Assignee
Forskarpatent I Syd Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forskarpatent I Syd Ab filed Critical Forskarpatent I Syd Ab
Priority to SE0302422A priority Critical patent/SE0302422D0/xx
Publication of SE0302422D0 publication Critical patent/SE0302422D0/xx
Priority to DK04775345T priority patent/DK1682578T3/da
Priority to DE602004014012T priority patent/DE602004014012D1/de
Priority to HK06110798.7A priority patent/HK1088909B/en
Priority to AT04775345T priority patent/ATE396203T1/de
Priority to ES04775345T priority patent/ES2309562T3/es
Priority to PCT/SE2004/001239 priority patent/WO2005023864A1/en
Priority to EP04775345A priority patent/EP1682578B1/de
Priority to US11/373,682 priority patent/US8436139B2/en
Priority to US11/875,247 priority patent/US20080070265A1/en
Priority to US12/262,284 priority patent/US20090092618A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0012—Lipids; Lipoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE0302422A 2003-09-11 2003-09-11 Peptide-based immunization therapy for treatment of atherosclerosis SE0302422D0 (sv)

Priority Applications (11)

Application Number Priority Date Filing Date Title
SE0302422A SE0302422D0 (sv) 2003-09-11 2003-09-11 Peptide-based immunization therapy for treatment of atherosclerosis
EP04775345A EP1682578B1 (de) 2003-09-11 2004-08-30 Auf peptiden basierende immunisierungstherapie zur behandlung von atheriosclerose
AT04775345T ATE396203T1 (de) 2003-09-11 2004-08-30 Auf peptiden basierende immunisierungstherapie zur behandlung von atheriosclerose
DE602004014012T DE602004014012D1 (de) 2003-09-11 2004-08-30 Auf peptiden basierende immunisierungstherapie zur behandlung von atheriosclerose
HK06110798.7A HK1088909B (en) 2003-09-11 2004-08-30 Peptide-based immunization therapy for treatment of atherosclerosis
DK04775345T DK1682578T3 (da) 2003-09-11 2004-08-30 Peptid-baseret immunoterapi til behandling af åreforkalkning
ES04775345T ES2309562T3 (es) 2003-09-11 2004-08-30 Terapia de inmunizacion basada en peptidos para el tratamiento de la aterosclerosis.
PCT/SE2004/001239 WO2005023864A1 (en) 2003-09-11 2004-08-30 Peptide-based immunization therapy for treatment of atherosclerosis
US11/373,682 US8436139B2 (en) 2003-09-11 2006-03-10 Peptide-based immunization therapy for treatment of atherosclerosis
US11/875,247 US20080070265A1 (en) 2003-09-11 2007-10-19 Peptide-based immunization therapy for treatment of atherosclerosis
US12/262,284 US20090092618A1 (en) 2003-09-11 2008-10-31 Peptide-based immunization therapy for treatment of atherosclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0302422A SE0302422D0 (sv) 2003-09-11 2003-09-11 Peptide-based immunization therapy for treatment of atherosclerosis

Publications (1)

Publication Number Publication Date
SE0302422D0 true SE0302422D0 (sv) 2003-09-11

Family

ID=28787306

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0302422A SE0302422D0 (sv) 2003-09-11 2003-09-11 Peptide-based immunization therapy for treatment of atherosclerosis

Country Status (8)

Country Link
US (3) US8436139B2 (de)
EP (1) EP1682578B1 (de)
AT (1) ATE396203T1 (de)
DE (1) DE602004014012D1 (de)
DK (1) DK1682578T3 (de)
ES (1) ES2309562T3 (de)
SE (1) SE0302422D0 (de)
WO (1) WO2005023864A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105003A1 (en) 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
SE0302422D0 (sv) * 2003-09-11 2003-09-11 Forskarpatent I Syd Ab Peptide-based immunization therapy for treatment of atherosclerosis
EP2222220B1 (de) * 2007-12-05 2016-03-16 The Cleveland Clinic Foundation Trimethylamin-verbindungen als mittel zur vorhersage des risikos für kardiovaskuläre erkrankungen
CU23736A1 (es) 2009-05-04 2011-11-15 Centro Inmunologia Molecular Anticuerpos que reconocen sulfatidos y proteoglicanos sulfatados y su uso
US8506964B2 (en) 2010-02-05 2013-08-13 Cardiovax, Llc Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis
RU2013126628A (ru) 2010-11-12 2014-12-20 Седарс-Синаи Медикал Сентер Иммуномодулирующие способы и системы для лечения и/или предотвращения аневризм
CA2817543A1 (en) 2010-11-12 2012-06-07 Cedars-Sinai Medical Center Immunomodulatory methods and systems for treatment and/or prevention of hypertension

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970144A (en) * 1984-12-31 1990-11-13 International Genetic Engineering Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use
US5972890A (en) * 1988-05-02 1999-10-26 New England Deaconess Hospital Corporation Synthetic peptides for arterial imaging
US5408038A (en) * 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
CA2142007C (en) * 1992-08-11 2007-10-30 Robert Glen Urban Immunomodulatory peptides
KR0185334B1 (ko) * 1995-11-02 1999-04-01 김은영 인간 혈장 아포지단백질 비-100에 결합하는 생쥐 항체를 암호하는 씨디엔에이
US6635623B1 (en) * 1997-06-13 2003-10-21 Baylor College Of Medicine Lipoproteins as nucleic acid vectors
US6156315A (en) * 1997-10-10 2000-12-05 The Trustees Of Columbia University In The City Of New York Method for inhibiting the binding of low density lipoprotein to blood vessel matrix
US20030157113A1 (en) * 1999-12-28 2003-08-21 Terman David S. Compositions and methods for treatment of neoplastic disease
SE0000855D0 (sv) * 2000-03-15 2000-03-15 Karolinska Innovations Ab Antigenic composition useful as a vaccine against atherosclerosis
SE0103754L (sv) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
US20030105003A1 (en) * 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
AU2002348241A1 (en) * 2001-11-24 2003-06-10 Image Analysis, Inc. Automatic detection and quantification of coronary and aortic calcium
US20040101874A1 (en) * 2002-04-12 2004-05-27 Mitokor Inc. Targets for therapeutic intervention identified in the mitochondrial proteome
SE0302422D0 (sv) * 2003-09-11 2003-09-11 Forskarpatent I Syd Ab Peptide-based immunization therapy for treatment of atherosclerosis

Also Published As

Publication number Publication date
HK1088909A1 (en) 2006-11-17
US20080070265A1 (en) 2008-03-20
WO2005023864A1 (en) 2005-03-17
ES2309562T3 (es) 2008-12-16
DE602004014012D1 (de) 2008-07-03
US20090092618A1 (en) 2009-04-09
US20060233817A1 (en) 2006-10-19
EP1682578B1 (de) 2008-05-21
ATE396203T1 (de) 2008-06-15
US8436139B2 (en) 2013-05-07
DK1682578T3 (da) 2008-10-27
EP1682578A1 (de) 2006-07-26

Similar Documents

Publication Publication Date Title
ATE510851T1 (de) Auf peptiden basierende immunisierungstherapie zur behandlung von atherosklerose
GT200600182A (es) Anticuerpos dirigidos contra el peptido amiloide beta y metodo que utilizan los mismos
NO20083793L (no) Antistoffer mot amyloid-beta peptid
Pathirana et al. Characterization of proteinase–adhesin complexes of Porphyromonas gingivalis
EA200700083A1 (ru) Антитела, направленные против бета-амилоидного пептида, и способы их применения
AT500379B8 (de) Tau-proteine
EA201000809A1 (ru) АНТИТЕЛА, СПЕЦИФИЧЕСКИЕ В ОТНОШЕНИИ ПРОТОФИБРИЛЛЯРНОЙ ФОРМЫ БЕЛКА β-АМИЛОИДА
AR033978A1 (es) Molecula de anticuerpo con especificidad para factor de necrosis tumoral alfa humano y usos de las mismas
AR066987A1 (es) Anticuerpo monoclonal contra proteina beta-amiloide
EA200401198A1 (ru) АНТИТЕЛА ПРОТИВ αvβ6
NO20043891L (no) Anti-A-beta-antistoffer og deres anvendelse
CY1115014T1 (el) ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ΕΙΔΙΚΑ ΓΙΑ Αβ1-42 ΜΕ ΘΕΡΑΠΕΥΤΙΚΕΣ ΙΔΙΟΤΗΤΕΣ
MA28982B1 (fr) Anticorps antagonistes de il-17
EP2532366A4 (de) Pharmazeutische zusammensetzung zur behandlung oder prävention von krebs
DE602005027258D1 (de) Humane monoklonale antikörper gegen hendra- und nipah-viren
EA200601946A2 (ru) Антитела, связывающиеся с белками steap-1, и их производные
MA31899B1 (fr) Anticorps monoclonaux qui se lient au hgm-csf et compositions medicales les comprenant
EA201070236A1 (ru) Фрагменты расщепления иммуноглобулинов в качестве индикаторов заболеваний и композиции для детекции и связывания таких фрагментов
Peng et al. Targeting a cysteine protease from a pathobiont alleviates experimental arthritis
DK1682578T3 (da) Peptid-baseret immunoterapi til behandling af åreforkalkning
NO20056055L (no) Fluorescein-labelled peptides
WO2004018511A3 (en) Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins
PL400309A1 (pl) Kwasy nukleinowe, proteiny oraz przeciwciala BTL-II
DE50111112D1 (de) Hyphenspezifische faktoren aus candida albicans
Taguchi et al. Development of an activity-based probe for amyloid β-hydrolyzing antibodies